Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Biliary Tract Cancer
Related studies linked through entity extraction aliases.
Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Study of Occupational Risk Factors for Biliary and Pancreatic Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Status
- RECRUITING
- Phase
- PHASE3
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study for AZD4360 in Participants With Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE3
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Status
- RECRUITING
- Phase
- PHASE2
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2